American College of Cardiology still concerned with 2027 Medicare Physician Fee Schedule

 

The American College of Cardiology (ACC) is raising concerns about several provisions in the 2027 Medicare Physician Fee Schedule (PFS), including a new heart failure payment model that could reduce physician reimbursement by up to 9%, payment cuts for several cardiovascular procedures and changes to how chronic patient care is reimbursed.

Christopher Kramer, MD, immediate past president of the ACC, said the college submitted extensive comments to the Centers for Medicare and Medicaid Services (CMS) and was disappointed several of its concerns were not addressed.

One of the ACC's biggest concerns with the new Medicare PFS is the new Ambulatory Specialty Model (ASM) for heart failure scheduled to take effect Jan. 1. Under the program, physicians who treat more than 20 heart failure patients annually in selected areas will be evaluated under new quality measures. Their Medicare reimbursement can increase by as much as 9% or decrease by up to 9%, depending on their performance.

"ACC thought this was premature to put in place," Kramer said. "It has not been piloted. It has not been tested. Only certain physicians were chosen to be participants, and it's not clear that the right physicians were chosen. These are not heart failure doctors, these are physicians who take care of heart failure patients and they could be general cardiologists, electrophysiologists, etc."

Subscribe to Cardiovascular Business News

ACC questions how CMS selected participating physicians, especially after reviewing the 2,600 cardiologists included in the program and finding that 500 should not have even been considered.

"We had asked CMS to maybe do a pilot, see how it worked maybe for a year and then institute the final model," Kramer said. "But that fell on deaf ears."

The organization is now educating cardiologists who have been selected to participate so they understand the program's requirements and quality measures.

There is a worry that physicians in rural areas with relatively few cardiologists could be disproportionately impacted by this new ASM. The model is intended to be budget-neutral, meaning reimbursement reductions for some physicians will offset increases for others. However, Kramer said the financial penalties could create unintended consequences for patient access in areas where there are few physicians to care for these patients.

In particular, he worries that general cardiologists may become less willing to treat heart failure patients if doing so exposes them to potential reimbursement reductions based on a relatively small patient population.

"General cardiologists have a need to see heart failure patients, the number one morbidity in the U.S. and a very common reason to seek cardiovascular care," he said.

If physicians begin referring these patients exclusively to heart failure specialists to avoid the financial risks, access could become more difficult in regions where there are not enough of these specialists, or it could require an hour or more of travel to visit the physician.

Kramer described the program as an early test of value-based healthcare, warning that it demonstrates the potential problems with this approach when implemented without sufficient testing and physician input.

Cardiovascular procedure reimbursement and imaging changes

The ACC also objected to reimbursement reductions for several cardiovascular procedures, including left atrial appendage occlusion (LAAO), tricuspid valve interventions and drug-coated balloon percutaneous coronary intervention (PCI). Kramer said these procedures require substantial physician time, effort and specialized training, making the proposed cuts particularly disappointing. He added that CMS generally did not provide specific explanations for the reductions despite the ACC's comments.

Another concern involves changes to the G2211 add-on code, which has provided additional reimbursement for physicians managing patients with ongoing, complex healthcare needs. Under the changes, reimbursement associated with the chronic care code is being shifted away from individual physicians and incorporated into global practice payments. While the overall payment is not changing, Kramer said the change removes relative value unit (RVU) credit from individual physicians, making it more difficult to account for their time and contributions to longitudinal patient care.

The ACC also opposed changes involving site-neutral payments for non-contrast imaging. The policy creates incentives to move certain imaging procedures out of hospital settings and into ambulatory or private practice environments.

Kramer said this could force changes in where cardiology practices perform imaging and how they organize their services. While independent practices could benefit from opportunities to expand imaging outside hospitals, he said the broader impact on hospital-based cardiology practices remains uncertain.

"We advocated against this change because we thought it would force a change in where practices did imaging," he said.

Changes to TAVR coverage and evidence requirements

Kramer also highlighted changes to the Medicare National Coverage Determination (NCD) for transcatheter aortic valve replacement (TAVR). The revised policy no longer requires coverage with evidence development for symptomatic patients undergoing TAVR. However, evidence requirements are now focused on patients with asymptomatic severe aortic stenosis. This shift could result in registry data that no longer accurately reflects the population of patients undergoing TAVR.

The ACC is continuing discussions with CMS regarding TAVR for severe aortic regurgitation. With a new FDA-cleared device available for treating the condition, Kramer said various organizations are working to determine the appropriate patient-selection criteria and how evidence should be collected to establish quality measures and guide clinical practice.

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: [email protected]

Subscribe to Cardiovascular Business News

Subscribe to Cardiovascular Business News